[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Rabizadeh et al., 2008 - Google Patents

New horizons for the infectious diseases specialist: how gut microflora promote health and disease

Rabizadeh et al., 2008

View HTML
Document ID
10614855380930809089
Author
Rabizadeh S
Sears C
Publication year
Publication venue
Current infectious disease reports

External Links

Snippet

The human intestine provides an expansive interface for interactions with the microflora. Increasing data support the hypothesis that host-microflora relationships are markedly dynamic, contributing to host health and disease pathogenesis. Despite outnumbering …
Continue reading at www.ncbi.nlm.nih.gov (HTML) (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Micro-organisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Micro-organisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca

Similar Documents

Publication Publication Date Title
Sorbara et al. Microbiome-based therapeutics
He et al. Faecalibacterium prausnitzii: A Next‐Generation Probiotic in Gut Disease Improvement
Barko et al. The gastrointestinal microbiome: a review
Lawley et al. Intestinal colonization resistance
Marasco et al. Gut microbiota and celiac disease
Malo et al. Intestinal alkaline phosphatase promotes gut bacterial growth by reducing the concentration of luminal nucleotide triphosphates
Berg et al. Can inflammatory bowel disease be permanently treated with short-term interventions on the microbiome?
Khanna et al. The microbiome in Crohn's disease: role in pathogenesis and role of microbiome replacement therapies
Lakshminarayanan et al. Compositional dynamics of the human intestinal microbiota with aging: implications for health
Doron et al. Probiotics: their role in the treatment and prevention of disease
Kamada et al. Control of pathogens and pathobionts by the gut microbiota
Haque et al. The ecological community of commensal, symbiotic, and pathogenic gastrointestinal microorganisms–an appraisal
Johnson et al. The human microbiome and its potential importance to pediatrics
Guarner Enteric flora in health and disease
Thomas et al. Exploring the influence of the gut microbiota and probiotics on health: a symposium report
Lobo et al. The interplay between microbiota and inflammation: lessons from peritonitis and sepsis
Tamboli et al. Probiotics in inflammatory bowel disease: a critical review
Blandino et al. Probiotics: overview of microbiological and immunological characteristics
Morowitz et al. The human microbiome and surgical disease
KR20180093903A (en) A microorganism therapeutic microarray for the treatment and / or prevention of food allergy
O'Connor et al. Gut microbiota in older subjects: variation, health consequences and dietary intervention prospects
Snelling Effects of probiotics on the gastrointestinal tract
Petersen et al. Some putative prebiotics increase the severity of Salmonella enterica serovar Typhimurium infection in mice
Santos-Paulo et al. The gut microbiota as a therapeutic target for obesity: a scoping review
Buddhasiri et al. Anti-inflammatory effect of probiotic Limosilactobacillus reuteri KUB-AC5 against Salmonella infection in a mouse colitis model